|
2024
|
Invention
|
Deuterated dydrogesterone. The present invention provides to deuterated dydrogesterone of formula... |
|
|
Invention
|
Lurbinectedin formulation. The present invention provides a stable, liquid ready-to-use injectabl... |
|
2022
|
Invention
|
Stable ready-to-use carmustine pharmaceutical composition. The present invention relates to a rea... |
|
2019
|
Invention
|
Improved kit for preparing injectable carmustine solutions. The present invention relates to an i... |
|
|
Invention
|
Stable ready-to-use carmustine pharmaceutical composition.
The present invention relates to a re... |
|
|
G/S
|
Organization of exhibitions, trade fairs, seminar and other events for commercial or advertising ... |
|
|
G/S
|
Pharmaceutical preparations for human purposes, namely, analgesics, antibiotics, anti-diabetics, ... |
|
|
Invention
|
Carmustine formulation.
The present invention relates to a composition comprising nitrosourea an... |
|
|
Invention
|
Carmustine formulation. The present invention relates to a composition comprising nitrosourea and... |
|
2018
|
Invention
|
Process for preparation of lanreotide acetate. The invention relates to an improved method for th... |
|
|
Invention
|
Particle size stabilization of protein bound particles and methods thereof. The present invention... |
|
|
Invention
|
Liquid formulation of cabazitaxel. The present invention relates to a stable liquid formulation o... |
|
|
Invention
|
Process for preparation of isoproterenol hydrochloride. The present invention provides a process ... |
|
2017
|
Invention
|
Lipid formulations of carmustine. The present invention relates to a pharmaceutical lipid composi... |
|
|
Invention
|
Lipid formulations of carmustine. AbstractThe conventional lyophilized formulation of carmu... |
|
|
Invention
|
Process for preparation of icatibant acetate.
The invention relates to an improved method for a ... |
|
|
Invention
|
Process for preparation of icatibant acetate. The invention relates to an improved method for a 5... |
|
|
Invention
|
Process for lanreotide acetate preparation. The invention relates to an improved method for 4+4 s... |
|
|
Invention
|
Pharmaceutical compositions of apixaban. The present invention relates to pharmaceutical composit... |
|
|
Invention
|
Process for preparation of lanreotide acetate. Disclosed herein is an improved 4+4 solution phase... |
|
|
Invention
|
Process for preparation of octreotide acetate. Disclosed herein is an improved 4+4 solution phase... |
|
|
Invention
|
Heterocyclic compounds useful as ido and/or tdo modulators. Present invention relates to novel he... |
|
|
Invention
|
Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter ... |
|
|
Invention
|
Process for preparation of prostacyclin derivatives. The invention relates to improved method of ... |
|
|
Invention
|
Process for preparation of prostacyclin derivatives. Disclosed is an improved method of synthesis... |
|
|
Invention
|
Pharmaceutical compositions of teriflunomide. The present invention relates to pharmaceutical com... |
|
2016
|
Invention
|
Sterile parenteral suspensions.
The present invention relates to bulk sterilized parenteral susp... |
|
|
Invention
|
Sterile parenteral suspensions. The present invention relates to bulk sterilized parenteral suspe... |
|
|
Invention
|
Process for preparation of trientine dihydrochloride. The present invention provides a process fo... |
|
|
Invention
|
An improved process for preparation of trientine dihydrochloride. The present invention provides ... |
|
|
Invention
|
Pyridone derivatives as acid secretion inhibitors and process for preparation thereof. 3 is methy... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of iron deficiency and anaemia due to iron deficien... |
|
|
Invention
|
Synthesis of raltegravir. The present invention relates to a novel synthetic route for the prepar... |
|
|
Invention
|
Liquid formulation of cabazitaxel.
The present invention relates to a stable liquid formulation ... |
|
|
Invention
|
Pharmaceutical composition of bortezomid. The present invention relates to a stable ready-to-use ... |
|
2015
|
G/S
|
Pharmaceutical preparations for human purposes, namely, analgesics, antibiotics, anti diabetics, ... |
|
|
Invention
|
Pharmaceutical compositions of vitamin kl. The present invention provides a pharmaceutical compos... |
|
|
Invention
|
Process for preparation of acitrecin. The present invention provides a process for preparation of... |
|
|
Invention
|
Process for preparation of acitretin. The present invention provides a process for preparation of... |
|
|
G/S
|
pharmaceuticals and medicinal preparations. |
|
2014
|
Invention
|
Improved fingolimod process. The present invention relates to a novel synthetic route for the pre... |
|
|
Invention
|
Fingolimod hydrochloride process. A process for preparation of diethyl 2-aetamido-2-(4-octyl phen... |
|
2013
|
G/S
|
Pharmaceutical and medicinal preparations and products for human use; sanitary preparations; diet... |
|
|
G/S
|
pharmaceutical preparations for human purposes, namely, [ analgesics, antibiotics, anti diabetics... |
|
1974
|
G/S
|
Anti-cancer agent. |
